Literature DB >> 27167679

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension.

Zhiyuan Ma1, Lan Mao1, Sudarshan Rajagopal2.   

Abstract

Pulmonary arterial hypertension (PAH) is a rare disease of the pulmonary vasculature characterized by endothelial cell apoptosis, smooth muscle proliferation and obliteration of pulmonary arterioles. This in turn results in right ventricular (RV) failure, with significant morbidity and mortality. Rodent models of PAH, in the mouse and the rat, are important for understanding the pathophysiology underlying this rare disease. Notably, different models of PAH may be associated with different degrees of pulmonary hypertension, RV hypertrophy and RV failure. Therefore, a complete hemodynamic characterization of mice and rats with PAH is critical in determining the effects of drugs or genetic modifications on the disease. Here we demonstrate standard procedures for assessment of right ventricular function and hemodynamics in both rat and mouse PAH models. Echocardiography is useful in determining RV function in rats, although obtaining standard views of the right ventricle is challenging in the awake mouse. Access for right heart catheterization is obtained by the internal jugular vein in closed-chest mice and rats. Pressures can be measured using polyethylene tubing with a fluid pressure transducer or a miniature micromanometer pressure catheter. Pressure-volume loop analysis can be performed in the open chest. After obtaining hemodynamics, the rodent is euthanized. The heart can be dissected to separate the RV free wall from the left ventricle (LV) and septum, allowing an assessment of RV hypertrophy using the Fulton index (RV/(LV+S)). Then samples can be harvested from the heart, lungs and other tissues as needed.

Entities:  

Mesh:

Year:  2016        PMID: 27167679      PMCID: PMC4941906          DOI: 10.3791/53335

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  19 in total

1.  Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

Authors:  N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension.

Authors:  Eleni Vergadi; Mun Seog Chang; Changjin Lee; Olin D Liang; Xianlan Liu; Angeles Fernandez-Gonzalez; S Alex Mitsialis; Stella Kourembanas
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

Review 3.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

Review 4.  Anesthesia for patients with pulmonary hypertension.

Authors:  Chad D Pritts; Ronald G Pearl
Journal:  Curr Opin Anaesthesiol       Date:  2010-06       Impact factor: 2.706

5.  Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice.

Authors:  Dennis Abraham; Lan Mao
Journal:  J Vis Exp       Date:  2015-09-17       Impact factor: 1.355

6.  Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension.

Authors:  Frances S de Man; M Louis Handoko; Joris J M van Ballegoij; Ingrid Schalij; Sylvia J P Bogaards; Pieter E Postmus; Jolanda van der Velden; Nico Westerhof; Walter J Paulus; Anton Vonk-Noordegraaf
Journal:  Circ Heart Fail       Date:  2011-12-09       Impact factor: 8.790

7.  Assessment of right ventricular structure and function in mouse model of pulmonary artery constriction by transthoracic echocardiography.

Authors:  Hui-Wen Cheng; Sudeshna Fisch; Susan Cheng; Michael Bauer; Soeun Ngoy; Yiling Qiu; Jian Guan; Shikha Mishra; Christopher Mbah; Ronglih Liao
Journal:  J Vis Exp       Date:  2014-02-03       Impact factor: 1.355

8.  A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension.

Authors:  Roxane Paulin; Gopinath Sutendra; Vikram Gurtu; Peter Dromparis; Alois Haromy; Steeve Provencher; Sebastien Bonnet; Evangelos D Michelakis
Journal:  Circ Res       Date:  2014-10-06       Impact factor: 17.367

9.  Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.

Authors:  Virak Mam; Alain F Tanbe; Sally H Vitali; Elena Arons; Helen A Christou; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2009-11-13       Impact factor: 4.030

10.  Progressive right ventricular functional and structural changes in a mouse model of pulmonary arterial hypertension.

Authors:  Zhijie Wang; David A Schreier; Timothy A Hacker; Naomi C Chesler
Journal:  Physiol Rep       Date:  2013-12-15
View more
  10 in total

1.  Targeting Pulmonary Endothelial Hemoglobin α Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction.

Authors:  Roger A Alvarez; Megan P Miller; Scott A Hahn; Joseph C Galley; Eileen Bauer; Timothy Bachman; Jian Hu; John Sembrat; Dmitry Goncharov; Ana L Mora; Mauricio Rojas; Elena Goncharova; Adam C Straub
Journal:  Am J Respir Cell Mol Biol       Date:  2017-12       Impact factor: 6.914

2.  Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through β-Arrestin 1.

Authors:  Zhiyuan Ma; Yen-Rei Yu; Cristian T Badea; Jeffrey J Kovacs; Xinyu Xiong; Suzy Comhair; Claude A Piantadosi; Sudarshan Rajagopal
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

Review 3.  'There and Back Again'-Forward Genetics and Reverse Phenotyping in Pulmonary Arterial Hypertension.

Authors:  Emilia M Swietlik; Matina Prapa; Jennifer M Martin; Divya Pandya; Kathryn Auckland; Nicholas W Morrell; Stefan Gräf
Journal:  Genes (Basel)       Date:  2020-11-26       Impact factor: 4.096

4.  Chronic Daily House Dust Mite Exposure in Mice is an Effective Model to Quantify the Effect of Pharmacologic Agents on Discrete Stages of Artery Remodeling in Pulmonary Hypertension.

Authors:  Lea C Steffes; Maya E Kumar
Journal:  Bio Protoc       Date:  2022-01-05

5.  Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats.

Authors:  Himanshu Meghwani; Pankaj Prabhakar; Soheb A Mohammed; Pamila Dua; Sandeep Seth; Milind P Hote; Sanjay K Banerjee; Sudheer Arava; Ruma Ray; Subir Kumar Maulik
Journal:  Medicines (Basel)       Date:  2018-04-17

6.  Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation.

Authors:  Haihua Qiu; Yibo Zhang; Zhongyu Li; Ping Jiang; Shuhong Guo; Yi He; Yuan Guo
Journal:  Front Cardiovasc Med       Date:  2021-03-15

7.  Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Downregulation of Soluble Guanylate Cyclase and Contributes to Exercise-Induced Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.

Authors:  Taijyu Satoh; Longfei Wang; Cristina Espinosa-Diez; Bing Wang; Scott A Hahn; Kentaro Noda; Elizabeth R Rochon; Matthew R Dent; Andrea R Levine; Jeffrey J Baust; Samuel Wyman; Yijen L Wu; Georgios A Triantafyllou; Ying Tang; Mike Reynolds; Sruti Shiva; Cynthia St Hilaire; Delphine Gomez; Dmitry A Goncharov; Elena A Goncharova; Stephen Y Chan; Adam C Straub; Yen-Chun Lai; Charles F McTiernan; Mark T Gladwin
Journal:  Circulation       Date:  2021-06-23       Impact factor: 39.918

8.  Pressure-based estimation of right ventricular ejection fraction: Validation as a clinically relevant target for drug development in a rodent model of pulmonary hypertension.

Authors:  Ahmed Elassal; Jochen Steppan; Sofia Charania; Lakshmi Santhanam; Inderjit Singh; Paul M Heerdt
Journal:  J Pharmacol Toxicol Methods       Date:  2021-07-07       Impact factor: 2.285

9.  Echocardiographic markers of pulmonary hemodynamics and right ventricular hypertrophy in rat models of pulmonary hypertension.

Authors:  Fotios Spyropoulos; Sally H Vitali; Marlin Touma; Chase D Rose; Carter R Petty; Philip Levy; Stella Kourembanas; Helen Christou
Journal:  Pulm Circ       Date:  2020-05-29       Impact factor: 3.017

10.  Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats.

Authors:  Olga Sadowska; Marta Baranowska-Kuczko; Anna Gromotowicz-Popławska; Michał Biernacki; Aleksandra Kicman; Barbara Malinowska; Irena Kasacka; Anna Krzyżewska; Hanna Kozłowska
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.